SBIR Phase II: Scalable Synthesis and Processing of Nanocrystalline Hydroxyapatite

Award Information
Agency:
National Science Foundation
Amount:
$499,999.00
Program:
SBIR
Contract:
0349884
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
2004
Phase:
Phase II
Agency Tracking Number:
0232733
Solicitation Topic Code:
N/A
Small Business Information
Angstrom Medica, Incorporated
150 California Street, Newton, MA, 02458
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 Edward Ahn
 PI
 (617) 454-3620
 eahn@angstrommedica.com
Business Contact
 Edward Ahn
Phone: (617) 454-3620
Email: eahn@angstrommedica.com
Research Institution
N/A
Abstract
This Small Business Innovation Research Phase II Project proposes to use a newly developed synthetic nanocrystalline hydroxyapatite (HAP) bone material to produce high-strength, resorbable synthetic bone implants for anterior cruciate ligament surgeries. This material solves the problem of current orthopedic implants (made of polymer and/or metal) which either permanently reside as foreign material in the body or quickly degrade into a formless mass of non-ossified, non-load bearing tissue. The objectives of the Phase II work are to concurrently scale up manufacturing processes for HAP to near-commercial levels while developing an anterior cruciate ligament (ACL) prototype product for testing in vivo. The commercial impact of this project will be in the area of orthopedics. The proposed technology will help decrease the time of healing in surgeries requiring implants (fractiures, ACL) and will minimize the need for second surgeries to remove the screws and/or to correct for morbidities.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government